Insmed
Open
$136.00
Prev. Close
$136.02
High
$136.00
Low
$135.79
Market Snapshot
$28.8B
-22.6
-5.57
$363.71M
The company is headquartered in Bridgewater, New Jersey and currently employs 1,664 full-time employees.
Insmed will showcase its advanced therapies and healthcare innovations at upcoming conferences in May 2026, highlighting its commitment to improving patient outcomes in lung diseases.
The company is headquartered in Bridgewater, New Jersey and currently employs 1,664 full-time employees.
Recently from Cashu
Insmed's Brensocatib Fails to Meet Efficacy Endpoints in Hidradenitis Suppurativa Study
Insmed Incorporated, known for its commitment to developing innovative therapies in the biotech sector, faces a significant setback as its Phase 2b clinical trial results on brensocatib for hidradenit…
Insmed's Arikayce Shows Promise in Treating Mycobacterium Avium Complex Infections
Promising Advancements in Mycobacterium Avium Complex Treatment Insmed Incorporated is making significant strides in the treatment of Mycobacterium avium complex (MAC) lung infections, a condition kno…
Insmed Grants Inducement Awards to Enhance Workforce Growth and Employee Engagement
Insmed's Commitment to Workforce Growth through Inducement Awards Insmed Incorporated, a global biopharmaceutical leader based in Bridgewater, New Jersey, recently takes a significant step in its grow…
Insmed Awards Inducement Packages to Attract and Retain Top Talent in Biopharmaceuticals
Insmed's Commitment to Talent Acquisition and Employee Retention Insmed Incorporated, a prominent biopharmaceutical company based in Bridgewater, New Jersey, demonstrates its commitment to attracting…